Clinical

Dataset Information

0

Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis


ABSTRACT: This phase II trial studies the effect of atorvastatin in treating patients with ulcerative colitis who have a dominant-negative missense P53 mutation and are at risk of developing large intestinal cancer. Patients with ulcerative colitis are known to have an increased risk of developing large intestinal cancer. Better ways to control ulcerative colitis and more knowledge about how to prevent colon cancer are needed. Atorvastatin is a drug used to lower the amount of cholesterol in the blood and to prevent stroke, heart attack, and angina (chest pain). It blocks an enzyme that helps make cholesterol in the body. It also causes an increase in the breakdown of cholesterol. The information gained from this study may help doctors learn more about atorvastatin as an agent in cancer prevention, and may help to improve public health.

DISEASE(S): Colitis, Ulcerative,Colorectal Carcinoma,Ulcerative Colitis,Colorectal Neoplasms,Colitis

PROVIDER: 2368403 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2010-11-20 | GSE25276 | GEO
2010-11-20 | E-GEOD-25277 | biostudies-arrayexpress
2010-11-20 | E-GEOD-25276 | biostudies-arrayexpress
2010-11-20 | GSE25275 | GEO
2010-11-20 | GSE25277 | GEO
2015-05-26 | PXD001608 | Pride
2019-09-08 | PXD014479 | Pride
2010-11-20 | E-GEOD-25275 | biostudies-arrayexpress
2019-07-10 | GSE134025 | GEO
2020-05-09 | GSE150115 | GEO